Johnson & Johnson
- A02 - Agentes para el tratamiento de alteraciones causadas por ácidos
- KOMPENSAN tablet 340 mg
- PARIET gastro-resistant tablet 20 mg
- A03 - Agentes contra padecimientos funcionales del estómago e intestino
- MOTILIUM oral suspension 1 mg/ml
- MOTILIUM tablet 10 mg
- D01 - Antifúngicos para uso dermatológico
- NIZORAL cream 2%
- NIZORAL shampoo 1%
- J02 - Antimicóticos de uso sistémico
- ITRASPOR capsule, hard 100 mg
- SPORANOX oral solution 10 mg/ml
- J05 - Antivirales de uso sistémico
- INCIVO film-coated tablet 375 mg
- INTELENCE tablet 100 mg
- PREZISTA tablet 400 mg
- PREZISTA tablet 800 mg
- L01 - Antineoplásicos
- CAELYX concentrate for solution for infusion 2 mg/ml
- DACOGEN powder for solution for infusion 50 mg
- IMBRUVICA capsule, hard 140 mg
- VELCADE powder for solution for injection 3.5 mg
- YONDELIS CONCENTRATE SOLUTION powder for solution for infusion 1 mg
- L02 - Terapia endocrina
- ZYTIGA tablet 250 mg
- L04 - Inmunosupresores
- STELARA PREFILLED SYRINGE solution for injection 45 mg
- STELARA PREFILLED SYRINGE solution for injection 90 mg
- M02 - Productos tópicos para dolor articular y muscular
- BEN GAY ointment
- N02 - Analgésicos
- DUROGESIC 5 TTS transdermal patch 100 µg
- DUROGESIC 5 TTS transdermal patch 12 µg
- DUROGESIC 5 TTS transdermal patch 25 µg
- DUROGESIC 5 TTS transdermal patch 50 µg
- DUROGESIC 5 TTS transdermal patch 75 µg
- JURNISTA prolonged-release tablet 16 mg
- JURNISTA prolonged-release tablet 32 mg
- JURNISTA prolonged-release tablet 8 mg
- N03 - Antiepilépticos
- TOPAMAX film-coated tablet 100 mg
- TOPAMAX film-coated tablet 200 mg
- TOPAMAX film-coated tablet 50 mg
- TOPAMAX SPRINKLE prolonged-release capsule, hard 15 mg
- N05 - Psicolépticos
- INVEGA prolonged-release tablet 3 mg
- INVEGA prolonged-release tablet 6 mg
- INVEGA prolonged-release tablet 9 mg
- RISPERDAL CONSTA LONG ACTING powder and solvent for suspension for injection 25 mg
- RISPERDAL CONSTA LONG ACTING powder and solvent for suspension for injection 37.5 mg
- RISPERDAL CONSTA LONG ACTING powder and solvent for suspension for injection 50 mg
- RISPERDAL oral solution 1 mg/ml
- RISPERDAL tablet 1 mg
- RISPERDAL tablet 2 mg
- RISPERDAL tablet 3 mg
- RISPERDAL tablet 4 mg
- XEPLION UZUN SALIMLI PREFILLED SYRINGE suspension for injection 100 mg/1 ml
- XEPLION UZUN SALIMLI PREFILLED SYRINGE suspension for injection 150 mg/1.5 ml
- XEPLION UZUN SALIMLI PREFILLED SYRINGE suspension for injection 50 mg/0.5 ml
- XEPLION UZUN SALIMLI PREFILLED SYRINGE suspension for injection 75 mg/0.75 ml
- N06 - Psicoanalépticos
- CONCERTA prolonged-release tablet 18 mg
- CONCERTA prolonged-release tablet 27 mg
- CONCERTA prolonged-release tablet 36 mg
- CONCERTA prolonged-release tablet 54 mg
- REMINYL oral solution 4 mg/ml
- REMINYL prolonged-release capsule, hard 16 mg
- REMINYL prolonged-release capsule, hard 24 mg
- REMINYL prolonged-release capsule, hard 8 mg
- N07 - Otros fármacos activos sobre el sistema nervioso
- NICORETTE FRESHFRUIT medicated chewing-gum 2 mg
- NICORETTE FRESHFRUIT medicated chewing-gum 4 mg
- NICORETTE FRESHMINT medicated chewing-gum 2 mg
- NICORETTE FRESHMINT medicated chewing-gum 4 mg
- NICORETTE INVISI transdermal patch 10 mg/16 h
- NICORETTE INVISI transdermal patch 15 mg/16 h
- NICORETTE INVISI transdermal patch 25 mg/16 h
- SIBELIUM capsule, hard 5 mg
- R06 - Antihistamínicos para uso sistémico
- UNISOM tablet 25 mg
- S01 - Oftalmológicos
- VISINE eye drops, solution 0.05%